Cargando…
Concurrent Disorder Management Guidelines. Systematic Review
Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The pur...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463987/ https://www.ncbi.nlm.nih.gov/pubmed/32731398 http://dx.doi.org/10.3390/jcm9082406 |
_version_ | 1783577260520898560 |
---|---|
author | Hakobyan, Syune Vazirian, Sara Lee-Cheong, Stephen Krausz, Michael Honer, William G. Schutz, Christian G. |
author_facet | Hakobyan, Syune Vazirian, Sara Lee-Cheong, Stephen Krausz, Michael Honer, William G. Schutz, Christian G. |
author_sort | Hakobyan, Syune |
collection | PubMed |
description | Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration. |
format | Online Article Text |
id | pubmed-7463987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74639872020-09-04 Concurrent Disorder Management Guidelines. Systematic Review Hakobyan, Syune Vazirian, Sara Lee-Cheong, Stephen Krausz, Michael Honer, William G. Schutz, Christian G. J Clin Med Review Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration. MDPI 2020-07-28 /pmc/articles/PMC7463987/ /pubmed/32731398 http://dx.doi.org/10.3390/jcm9082406 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hakobyan, Syune Vazirian, Sara Lee-Cheong, Stephen Krausz, Michael Honer, William G. Schutz, Christian G. Concurrent Disorder Management Guidelines. Systematic Review |
title | Concurrent Disorder Management Guidelines. Systematic Review |
title_full | Concurrent Disorder Management Guidelines. Systematic Review |
title_fullStr | Concurrent Disorder Management Guidelines. Systematic Review |
title_full_unstemmed | Concurrent Disorder Management Guidelines. Systematic Review |
title_short | Concurrent Disorder Management Guidelines. Systematic Review |
title_sort | concurrent disorder management guidelines. systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463987/ https://www.ncbi.nlm.nih.gov/pubmed/32731398 http://dx.doi.org/10.3390/jcm9082406 |
work_keys_str_mv | AT hakobyansyune concurrentdisordermanagementguidelinessystematicreview AT vaziriansara concurrentdisordermanagementguidelinessystematicreview AT leecheongstephen concurrentdisordermanagementguidelinessystematicreview AT krauszmichael concurrentdisordermanagementguidelinessystematicreview AT honerwilliamg concurrentdisordermanagementguidelinessystematicreview AT schutzchristiang concurrentdisordermanagementguidelinessystematicreview |